References
Bagley CM Jr, Thomas LB, Johnson RE, Chretien PB, de Vita VT Jr (1973) Diagnosis of liver involvement by lymphoma: results in 96 consecutive peritoneoscopies. Cancer 31:840–847
Givler RL, Brunk SF, Hass CA, Gulesserian HP (1971) Problems of interpretation of liver biopsy in Hodgkin’s disease. Cancer 28:1335–1342
Hubscher SG, Lumley MA, Elias E (1993) Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin’s lymphoma. Hepatology 17:70–77
De Medeiros BC, Lacerda MA, Telles JE, da Silva JA, de Medeiros CR (1998) Cholestasis secondary to Hodgkin’s disease: report of 2 cases of vanishing bile duct syndrome. Hematologica 83:1038–1040
Allory Y, Metreau J, Zafrani E (2000) Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin’ disease. Ann Pathol 20:52–55
Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Mackayekhi JP, Moreau A, et al. (1992) Drug-induced prolonged cholestasis in adults: a histological semiquantative study demonstrating progressive ductopenia. Hepatology 15:244–251
Yalçin Ş, Kars A, Sökmensüer C, Atahan L (1999) Extrahepatic Hodgkin’s disease with intrahepatic cholestasis: report of two cases. Oncology 57:83–85
Ludwig J, Wiesner RH, La Russo NF (1988) Idiopathic adulthood ductopenia: a cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 7:193–199
Alam I, Ferrell LD, Bass NM (1996) Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol 91:1626–1630
De Galoscy C, Horsmans Y, Rahier J, Geubel AP (1994) Vanishing bile duct syndrome occurring after carbamazepine administration: a second case report. J Clin Gastroenterol 19:269–271
Moradpour D, Altorfer J, Flury R, Greminger P, Meyenberger C, Jost R, Schmid M (1994) Chlorpromazine induced vanishing bile syndrome leading to biliary cirrhosis. Hepatology 20:1437–1441
Altraif I, Lily L, Wanless IR, Heatcote J (1994) Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamehoxazole. Am J Gastroenterol 89:1230–1234
Arnold JC, Portmann BC, O’Grady JG, Naoumov NV, Alexander GJ, Williams R (1992) Cytomegalovirus infection persists in the liver graft in vanishing bile duct syndrome. Hepatology 16:494–496
Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J (1991) Vanishing bile-duct syndrome following liver transplantation — is it reversible? Transplantation 51:1004–1010
Hoffmann RM, Gunther C, Diepolder HM, Zachoval R, Eissner HJ, Forst H, et al. (1995) Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation. Transpl Int 8:353–859
Yeh KH, Hsieh HC, Tang JL, Lin MT, Yang CH, Chen YC (1994) Severe isolated acute hepatic graft-versus — host disease with vanishing bile duct syndrome. Bone Marrow Transplant 14:319–321
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kömürcü, Ş., Özet, A., Altundag, M.K. et al. Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin’s disease. Ann Hematol 81, 57–58 (2002). https://doi.org/10.1007/s00277-001-0406-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-001-0406-7